glp 1 nausea and diarrhea glp-1 receptor agonist management Side Effects: A Complete Guide to What You Can Expect Exploring the Side Effects of – Your guide to GLP-1 side

It offers the convenience of oral dosing with the backing of clinical trial data, regulatory oversight, and standardized manufacturing

In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]

2 Although practice now favours earlier use of newer agents shown to have cardiorenal benefits, SUs are still used extensively across the UK, despite causing weight gain and hypoglycaemia

J.GarfieldA